Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy.

Jose Fernando Camargo Maria Alejandra MendozaRick LinIlona V MorozAnthony D AndersonMichelle I MorrisYoichiro NatoriAkina NatoriMohammed RajaLazaros LekakisAmer BeitinjanehAntonio JimenezMark GoodmanTrent WangKrishna V KomanduriDenise Pereira

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2021)

Mortality in COVID-19 HCT patients is higher than that of the age-comparable general population and largely dependent on age, disease severity, timing from HCT, and intensity of immunosuppression.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
stem cells
type diabetes
cardiovascular disease
adipose tissue
metabolic syndrome
cell proliferation
patient reported outcomes
risk factors
skeletal muscle
weight loss